001     268729
005     20240611120549.0
024 7 _ |a 10.1084/jem.20221190
|2 doi
024 7 _ |a pmid:38517332
|2 pmid
024 7 _ |a pmc:PMC10959724
|2 pmc
024 7 _ |a 0022-1007
|2 ISSN
024 7 _ |a 1540-9358
|2 ISSN
024 7 _ |a 1540-9538
|2 ISSN
024 7 _ |a altmetric:161076572
|2 altmetric
037 _ _ |a DZNE-2024-00305
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Brenner, David
|0 P:(DE-2719)9002137
|b 0
|u dzne
245 _ _ |a A TBK1 variant causes autophagolysosomal and motoneuron pathology without neuroinflammation in mice.
260 _ _ |a New York, NY
|c 2024
|b Rockefeller Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1718023951_5322
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Heterozygous mutations in the TBK1 gene can cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The majority of TBK1-ALS/FTD patients carry deleterious loss-of-expression mutations, and it is still unclear which TBK1 function leads to neurodegeneration. We investigated the impact of the pathogenic TBK1 missense variant p.E696K, which does not abolish protein expression, but leads to a selective loss of TBK1 binding to the autophagy adaptor protein and TBK1 substrate optineurin. Using organelle-specific proteomics, we found that in a knock-in mouse model and human iPSC-derived motor neurons, the p.E696K mutation causes presymptomatic onset of autophagolysosomal dysfunction in neurons precipitating the accumulation of damaged lysosomes. This is followed by a progressive, age-dependent motor neuron disease. Contrary to the phenotype of mice with full Tbk1 knock-out, RIPK/TNF-α-dependent hepatic, neuronal necroptosis, and overt autoinflammation were not detected. Our in vivo results indicate autophagolysosomal dysfunction as a trigger for neurodegeneration and a promising therapeutic target in TBK1-ALS/FTD.
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Protein Serine-Threonine Kinases
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 7 |a TBK1 protein, human
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 7 |a Tbk1 protein, mouse
|0 EC 2.7.1.-
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Amyotrophic Lateral Sclerosis: pathology
|2 MeSH
650 _ 2 |a Frontotemporal Dementia: genetics
|2 MeSH
650 _ 2 |a Frontotemporal Dementia: metabolism
|2 MeSH
650 _ 2 |a Frontotemporal Dementia: pathology
|2 MeSH
650 _ 2 |a Motor Neurons: pathology
|2 MeSH
650 _ 2 |a Mutation
|2 MeSH
650 _ 2 |a Neuroinflammatory Diseases
|2 MeSH
650 _ 2 |a Phosphorylation
|2 MeSH
650 _ 2 |a Protein Serine-Threonine Kinases: genetics
|2 MeSH
650 _ 2 |a Protein Serine-Threonine Kinases: metabolism
|2 MeSH
700 1 _ |a Sieverding, Kirsten
|0 P:(DE-2719)9002569
|b 1
700 1 _ |a Srinidhi, Jahnavi
|0 0009-0003-8416-2276
|b 2
700 1 _ |a Zellner, Susanne
|0 0000-0002-8523-824X
|b 3
700 1 _ |a Secker, Christopher
|0 P:(DE-2719)9000380
|b 4
700 1 _ |a Yilmaz, Rüstem
|0 0000-0002-4261-5236
|b 5
700 1 _ |a Dyckow, Julia
|0 0000-0003-1423-9322
|b 6
700 1 _ |a Amr, Shady
|0 0009-0000-1597-1510
|b 7
700 1 _ |a Ponomarenko, Anna
|0 0009-0009-9223-9310
|b 8
700 1 _ |a Tunaboylu, Esra
|0 0009-0002-4266-4449
|b 9
700 1 _ |a Douahem, Yasmin
|0 0009-0004-7079-7120
|b 10
700 1 _ |a Schlag, Joana S
|0 0009-0005-2001-4121
|b 11
700 1 _ |a Rodriguez Martinez, Lucia
|0 P:(DE-2719)9001702
|b 12
|u dzne
700 1 _ |a Kislinger, Georg
|0 P:(DE-2719)9000614
|b 13
700 1 _ |a Niemann, Cornelia
|0 P:(DE-2719)9001883
|b 14
|u dzne
700 1 _ |a Nalbach, Karsten
|0 P:(DE-2719)9002811
|b 15
|u dzne
700 1 _ |a Ruf, Wolfgang P
|0 P:(DE-2719)9001522
|b 16
700 1 _ |a Uhl, Jonathan
|0 0009-0005-1754-173X
|b 17
700 1 _ |a Hollenbeck, Johanna
|0 0009-0009-9877-7822
|b 18
700 1 _ |a Schirmer, Lucas
|0 0000-0001-7142-4116
|b 19
700 1 _ |a Catanese, Alberto
|0 P:(DE-2719)9001873
|b 20
|u dzne
700 1 _ |a Lobsiger, Christian S
|0 0000-0002-4313-010X
|b 21
700 1 _ |a Danzer, Karin M
|0 P:(DE-2719)9001513
|b 22
700 1 _ |a Yilmazer-Hanke, Deniz
|0 0000-0003-1483-0286
|b 23
700 1 _ |a Münch, Christian
|0 0000-0003-3832-090X
|b 24
700 1 _ |a Koch, Philipp
|0 P:(DE-2719)9002165
|b 25
|u dzne
700 1 _ |a Freischmidt, Axel-Dieter
|0 P:(DE-2719)9001054
|b 26
700 1 _ |a Fetting, Martina
|0 P:(DE-2719)2812260
|b 27
700 1 _ |a Behrends, Christian
|0 0000-0002-9184-7607
|b 28
700 1 _ |a Parlato, Rosanna
|0 0000-0001-6682-9645
|b 29
700 1 _ |a Weishaupt, Jochen H
|0 P:(DE-2719)9000455
|b 30
773 _ _ |a 10.1084/jem.20221190
|g Vol. 221, no. 5, p. e20221190
|0 PERI:(DE-600)1477240-1
|n 5
|p e20221190
|t Journal of experimental medicine
|v 221
|y 2024
|x 0022-1007
856 4 _ |u https://pub.dzne.de/record/268729/files/DZNE-2024-00305%20SUP.zip
856 4 _ |u https://pub.dzne.de/record/268729/files/DZNE-2024-00305.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/268729/files/DZNE-2024-00305.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:268729
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 0
|6 P:(DE-2719)9002137
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)9001702
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 13
|6 P:(DE-2719)9000614
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)9001883
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 15
|6 P:(DE-2719)9002811
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 16
|6 P:(DE-2719)9001522
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 20
|6 P:(DE-2719)9001873
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 22
|6 P:(DE-2719)9001513
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 25
|6 P:(DE-2719)9002165
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 27
|6 P:(DE-2719)2812260
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 1
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-24
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b J EXP MED : 2022
|d 2023-08-24
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J EXP MED : 2022
|d 2023-08-24
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-24
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-24
920 1 _ |0 I:(DE-2719)1110008
|k AG Simons
|l Molecular Neurobiology
|x 0
920 1 _ |0 I:(DE-2719)1110000-4
|k AG Misgeld
|l Neuronal Cell Biology
|x 1
920 1 _ |0 I:(DE-2719)5000072
|k AG Danzer
|l Mechanisms of Propagation
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1110008
980 _ _ |a I:(DE-2719)1110000-4
980 _ _ |a I:(DE-2719)5000072
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21